ArticleActa paediatrica (Oslo, Norway : 1992)2026
Fasting Biomarkers and Glycated Haemoglobin Identify Children With Excess Weight at Risk of Dysglycaemia and Guide Oral Glucose Tolerance Testing.
Article in Acta paediatrica (Oslo, Norway : 1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimChildhood obesity has been strongly associated with insulin resistance and dysglycaemia. We aimed to evaluate fasting biomarkers and glycated haemoglobin (HbA1c) for identifying children at risk and guiding the need for oral glucose tolerance testing (OGTT).
methodsThis single-centre study included 475 consecutive children aged 5-18 years with excess weight who underwent OGTT. Insulin resistance and dysglycaemia were defined based on OGTT-derived indices. Fasting glucose (FG), fasting insulin (FI), homeostatic model assessment of insulin resistance (HOMA-IR), homeostatic model assessment of β-cell function (HOMA-β), and HbA1c were evaluated. Receiver operating characteristic (ROC) analysis was used to determine optimal cut-offs for predicting dysglycaemia.
resultsThe cohort comprised 281 girls (59.2%) and 194 boys, with a median age of 13.8 years. Insulin resistance was present in 81.5% (387/475) and dysglycaemia in 18.9% (90/475). FG above the 90th percentile, FI and HOMA-IR above the 97.5th percentile, and HbA1c ≥ 39 mmol/mol (5.7%) were significantly associated with dysglycaemia (p < 0.05). ROC analysis for the entire cohort identified FG 5.27 mmol/L, HbA1c 39 mmol/mol, and HOMA-IR 4.88 as significant cut-offs (all p < 0.001).
conclusionFasting biomarkers and HbA1c identified children with excess weight at risk of dysglycaemia, providing practical thresholds to guide the need for OGTT.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.